Further guidance is available at nhs.uk
PMID: 32202086
The information on this page is provided for educational and informational purposes only & is not intended to replace professional medical advice, diagnosis, or treatment
Semaglutide, on the other hand, is also available under another brand name, Wegovy, which is specifically approved for weight management in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol
Animal and translational work hints at synergy between estrogen signaling and GLP-1 pathways, raising the possibility that fluctuating sex hormone states (menstrual cycle, menopause, exogenous hormones) may shape both efficacy and side-effect profiles (Vigil et al., 2022